As the COVID-19 virus continues to evolve, a new round of shots is slated to reach Americans in the coming months. The newest vaccines are spinoffs of JNJ-1. 11. 1, a direct descendant of JNJ-1, which has taken over as the primary strain circulating in the US. Specifically, KP. 3, KP. 2, and KP. 1. 1, also known as FLiRT variants, are currently dominant.
According to CDC data, KP. 3 comprised a quarter of all new US cases as of June 8… while KP. 2 made up 22. 5%. Federal health officials have long warned that Americans can expect annual updates to COVID-19 shots as the virus produces new strains that can evade immunity from previous vaccinations or infections – protection that also wanes over time.
This process is similar to how the US rolls out new flu vaccines every year. Companies have presented data showing that a JNJ-1COVID vaccine should produce higher levels of protective antibodies against circulating variants compared to currently approved shots targeting the XBB. 1. 5 omicron variant, which is no longer in circulation.
Once the FDA approves the vaccines, the shots will need recommendations from an advisory panel to the CDC and the agency itself before they can be rolled out to Americans. The CDC advisory committee is scheduled to meet at the end of the month to vote on who should receive the new round of vaccines this fall. The bigger question is… how many people will actually get vaccinated later this year? The availability of these new shots is a crucial step in combating the ongoing pandemic.
As the virus continues to evolve, “it’s essential to have updated vaccines to keep pace.” The new round of vaccines offers hope for further protection againstCOVID-19. According to CNBC, “this information was first published.”
More details: Found here
Covid Vaccine Updates Coming
Get ready to roll up your sleeves, folks! Covid vaccine updates are just around the corner. As the virus continues to evolve, scientists are working tirelessly to develop new rounds of shots that will keep us protected against the latest strains. According to the latest data from the CDC, several variants, including KP. 3 and KP. 2, are currently circulating in the US. These new strains have prompted the need for updated vaccines that can provide stronger immunity against the ever-changing virus. Think of it like getting a booster shot for your immunity – it’s a vital step in combating the ongoing pandemic.
Companies are taking a cue from their work on other vaccines, like the flu shot, to develop new Covid vaccines. In fact… data shows that a JNJ-1 COVID vaccine could produce higher levels of protective antibodies against the circulating variants compared to previously approved shots. That’s good news, especially for those of us who’ve already had their fair share of jabs.
So, when can we expect these new vaccines to roll out? Well, the FDA still needs to give its approval, and then it’ll be up to the CDC’s advisory committee to give the green light. According to the latest schedules, they’re set to meet at the end of the month to make some big decisions. Now, the big question on everyone’s mind: how many people will actually get vaccinated with these new shots? That’s a tough one… but what’s clear is that having updated vaccines in the pipeline is a crucial step in keeping us safe fromCOVID-19. So, “stay tuned for more updates on the Covid vaccine front.” In the meantime, “remember that this information was first published on CNBC.”
●●● ●●●
A new round of Covid shots will likely reach Americans in the coming months. Here’s what we know about the newest vaccines so far.
Several spinoffs of JN.1.11.1, a direct descendant of JN.1, have since taken over as the primary strains circulating in the U.S. That includes KP.3, KP.2 and KP.1.1, which are also known as FLiRT variants .
